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Abstract
Background: Pre-exposure-prophylaxis (PrEP) has been heralded for its potential to put women in control of
preventing HIV infection, but uptake and continuation rates have been disappointing in high-incidence settings in
sub-Saharan Africa. We explored structural and social factors that influenced PrEP use among young women and
pregnant or breastfeeding women in rural Eswatini.
Methods: We conducted two in-depth interviews with ten women on PrEP, and one-time in-depth interviews with
fourteen women who declined or discontinued PrEP. Interviews covered decision-making processes around PrEP
initiation and experiences with pill-taking. In-depth interviews were conducted with nine health workers, covering
experiences in delivering PrEP services, and two focus group discussions were held with men to elicit their
perceptions of PrEP. Interviews and discussions were audio-recorded, translated, transcribed and analysed
thematically, using an inductive approach.
Results: PrEP initiation and use were experienced by many women as empowering them to take control of their
health and well-being, and stay HIV free, facilitating them to realise their aspirations relating to motherhood and
educational attainment. However, the social norms that defined relationship dynamics with partners or family
members either undermined or promoted this empowerment potential. In particular, young women were rarely
supported by family members to take PrEP unless it was perceived to be for protecting an unborn child.
Stigmatisation of pill-taking through its associations with HIV and the burden of daily pill-taking also contributed to
PrEP discontinuation.
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Conclusions: Unlike many prevention tools, PrEP enabled women to achieve a sense of control over their lives.
Nevertheless, women’s agency to continue and adhere to PrEP was influenced by social and structural factors
including gender norms, family expectations of young women, relationship dynamics and stigma related to HIV.
Future interventions should address these barriers to promote PrEP use among sexually-active women.
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Background
The HIV epidemic in Eswatini (formerly Swaziland) re-
mains a public health concern, with persistently high
levels of incidence, particularly among women of repro-
ductive age [1–3]. By 2018, HIV prevalence was 27% in
the general adult population compared with 35% among
women, and annual HIV incidence was 1.2 per 100
person-years among women aged 15–49 years, compared
to 0.8 per 100 person-years in men [1]. HIV estimated in-
cidence is also higher in young women aged 15–24 years
at 1.9 per 100 person-years, compared to their male peers
among whom it reaches 0.8 per 100 person-years [3],
demonstrating the need for HIV preventive measures for
adolescent girls and young women (AGYW) in this set-
ting. Furthermore, biological changes during pregnancy
and the postpartum period, such as hormonal and im-
mune responses, increase HIV susceptibility among
women [4, 5]. This increased susceptibility together with
the risk of mother-to-child transmission makes pregnant
and breastfeeding women (PBW) an important target
groups for HIV preventive measures including pre-
exposure prophylaxis (PrEP).
The widespread provision of antiretroviral therapy
(ART) and behavioural interventions such as promoting
partner reduction and condom use have been insufficient
for HIV epidemic control, even when coupled with bio-
medical prevention interventions such as male circumci-
sion [6–9]. In 2015, the World Health Organization
(WHO) recommended PrEP for people at high risk of
HIV acquisition, defined as groups with incidence above 3
per 100 person-years [10], following several studies dem-
onstrating its effectiveness in reducing HIV infections
among high-risk populations [11, 12].
Female-initiated biomedical HIV prevention technolo-
gies such as PrEP have been heralded as offering new
possibilities for women to reduce their HIV risks by giv-
ing them control over the decision to use them [13].
However, the promotion of ART prevention approaches
(e.g. PrEP, prevention of mother-to-child transmission)
also imbues the person taking the medication with a re-
sponsibility to care for their own and others’ health that
can be either empowering or a burden [14–17]. Despite
the empowering and agential potential of health tech-
nologies, studies show how beneficiaries struggle to take
on the necessary responsibilities, potentially leading to
an exclusion of those unable to become sufficiently re-
silient [15, 17, 18]. In this vein, Rose and Lentzos (2017)
argue for a greater understanding of the collective condi-
tions, power and resources that are necessary to ensure
that responsibility and resilience become a reality [19]. It
is only when these conditions are met that PrEP can
move beyond being simply a medical prescription, to-
wards achieving its potential as a tool to enable women
to enact the agency that is necessary for securing their
health and quality of life on a daily basis [16].
In practice, social barriers including HIV stigma and
structural factors such as those that impede regular ac-
cess to health facilities [18, 20–23] may undermine the
empowerment potential of PrEP, but few studies have
explored how women experience these opposing dynam-
ics. In this context, we explored the structural and social
factors that influence experience of PrEP use and con-
tinuation among AGYW and PBW.
Methods
Study setting
Since 2007, Médecins sans Frontières (MSF), in collabor-
ation with the Ministry of Health, has been providing HIV
care in the predominantly rural Shiselweni region of Eswa-
tini. In 2017, a PrEP demonstration project investigated
PrEP provision among the general population. A nested
qualitative study explored the structural and social factors
that influenced PrEP experiences of AGYW aged 16–25
years and PBW aged ≥16 years to inform national PrEP
roll-out.
Sampling and recruitment
We purposively sampled participants for IDIs to include
clients with a variety of PrEP histories. Sampling in-
cluded AGYW or PBW who i) had been on PrEP for up
to 6months; ii) had initiated PrEP in the previous
month; iii) had been offered PrEP but declined to initi-
ate; iv) discontinued PrEP at the first monthly visit at
the health facility; v) discontinued PrEP after the first
prescription without returning to the health facility
(Table 1).
HIV counsellors recruited AGYW and PBW, explain-
ing the study before seeking permission for the research
team to phone them to schedule an interview. Men for
FGDs were recruited during health promotion sessions
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targeting men. Health workers involved in the delivery
of PrEP services were purposively sampled from four fa-
cilities, ensuring the inclusion of different cadres and
roles (Table 2).
Data generation
We conducted two rounds of in-depth interviews
(IDIs) with seven PBW and three AGYW who were
not pregnant or breastfeeding. The first interview cov-
ered their personal circumstances, reasons for initiat-
ing PrEP and early experiences with pill-taking, while
the second interview covered later experiences with
PrEP and any evolution in their personal
circumstances. We conducted one-time IDIs with 14
AGYW and PBW who declined or discontinued PrEP,
exploring reasons for these decisions, and with 11
healthcare workers to explore their experiences of
providing PrEP services and their suggestions for im-
proving PrEP uptake and retention. Interviews lasted
approximately 60–90 min, and were conducted in a
private place of the participant’s choice by the lead
author, a trained anthropologist (PB), and/or a local
qualitative research assistant (NM or VD), matched to
the sex of the participant. After each interview, notes
and observations from interviews were written up and
debriefing sessions were held between the interview-
ing team.
We conducted two focus group discussions (FGDs)
with 11 men from the community, exploring perceptions
of and attitudes towards PrEP. These were held in the
community, facilitated by the two local research assis-
tants (VD and NM) and lasted approximately 1 h. The
age range of the men was 18 to 60 years of age.
Data analysis
IDIs and FGDs were conducted in SiSwati and
audio-recorded following informed written consent.
Audio-recordings were translated and transcribed
into English.. Thematic analysis was conducted
whereby transcripts, fieldworker notes and observa-
tion templates were coded iteratively and inductively
in NVivo10 by PB, NM and VD. Codes were progres-
sively incorporated into a coding framework that was
developed continually to enable inclusion of emer-
ging categories, and analytical memos were written
to aid the process of raising findings to a conceptual
level and to explore relationships between emerging
themes.
Table 1 Respondent characteristics of PrEP clients (n = 24
respondents)






Declined PrEP 5 (21)
On PrEP < 1 month 9 (38)
On PrEP > 1 month 1 (4)
Discontinued PrEP 9 (38)
Relationship status
Multiple partners 3 (13)
Partner, living together 3 (13)
Partner, not living together 17 (71)
Single 1 (4)
Status of partner(s)
Known HIV-serodiscordant relationship 6 (25)
Non−/unknown HIV-serodiscordant relationship 18 (75)
Children
No children 2 (8)
Pregnant 3 (13)
1 child 11 (46)









In school 7 (29)







HIV testing lay counsellors 6 (55)
Community mobiliser 1 (9)




> 10 2 (18)
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Results
HIV risks
Most women felt at risk of HIV infection due to rela-
tionships that they characterized as lacking mutual trust,
unreliable and unstable, as well as difficulties negotiating
condom use with their partners. Women described how
sexual relationships and encounters were difficult to pre-
dict and control – for example, due to having a migrant
partner who would turn up unannounced or because
they were linked to economic reasons. Unplanned, and
often unwanted, pregnancies made women feel
dependent on their child’s father as a breadwinner, par-
ticularly as most women were unemployed and unable
to provide for a child alone. This economic dependence
inclined women to stay in relationships where they felt
at risk of HIV.
PrEP as an enactment of agency and self-care
Women highlighted several ways through which PrEP
represented an enactment of agency, enabling them to
take control of HIV risks and protect themselves and/or
their baby from HIV infection. It afforded them peace of
mind and confidence that they would not become in-
fected, which in turn would ensure that they could stay
healthy and see their children grow up. This motivation
could lead them to overcome financial barriers to clinic
attendance:
I’m committed to this [PrEP]. Even if I don’t have
transport money, I’ll rather try borrowing it from
neighbours, so I’m able to go to the clinic to get my
PrEP pills. Then I can raise my children properly
and not end up having HIV (Woman 21–25 years).
Continually testing HIV-negative, when coming to
follow-up visits at the clinic, reaffirmed women’s con-
fidence in their choice to initiate PrEP. Most women
described the decision to initiate PrEP as being their
own to take, appreciating the autonomy that this
afforded them by removing the need to negotiate with
their partners as was the case with condoms. How-
ever, some were later confronted by partners who felt
they should have been included in the decision.
PrEP use also evoked a sense of responsibility and
care for one’s own life and self-worth. Some women
recounted how PrEP had served as a reminder of the
importance of taking care of themselves, and had
even encouraged them to negotiate condom use in
their relationship again:
Now when we have sex, we use condoms. Before I
started PrEP, we weren’t using condoms. The pill en-
courages me to use condoms and to know that I will
not end up getting infected (Woman 18–20 years).
For AGYW, both PrEP and contraceptive pills were
seen as items that would enable them to fulfil future
educational and career aspirations, essential for the fi-
nancial independence that many craved, and that they
believed would be undermined if they seroconverted or
fell pregnant:
I want to finish school, while not having a baby and
I did PrEP because I don’t want to be HIV-positive.
[…] I do not trust love; rather I trust that PrEP and
Jadelle [contraceptive implant] will help me
(Woman 18–20 years).
“PrEP for life” and pill fatigue
While PrEP enabled some to exert a degree of agency in
their sexual lives, the unpredictability and lack of control
that characterized the women’s sexual relationships led
them to perceive their need for PrEP as lifelong or con-
tinuous until they found a stable partner or got married.
This in turn could lead to pill fatigue and discontinued
use, with some PrEP using participants starting to ques-
tion the relative advantages of taking antiretroviral
(ARV) drugs for prevention over taking ARVs for treat-
ment, given the perceived similarity in the pill-taking
burden:
I was tired of the pills, they are big and like ARVs.
You have to take them every day and they are diffi-
cult to swallow. I felt like I have to take it for the rest
of my life […] It is like I already have the virus
(Woman 21–25 years).
All the women in HIV-serodiscordant relationships
stated that their partner was on ART. However, some did
not seem to know that this would reduce their HIV infec-
tion risk, nor did they know their partner’s viral load (VL)
results. Furthermore, a few of the women who were inter-
viewed expressed uncertainty as to whether their partners
were taking ARVs as prescribed, and understood that this
perceived lack of responsibility on the part of their partner
increased the risk of acquiring HIV:
I feel at risk, even though he is taking the pills
[ARVs], I am not convinced I am safe. He is not re-
sponsible. Sometimes he goes somewhere and comes
home late and then he will not be able to take his
pills (Woman 21–25 years).
Healthcare workers suggested that they started clients
on PrEP if they were in HIV-serodiscordant relationships
without further inquiry as to the HIV-infected partner’s
VL result. They sometimes struggled to assess clients’
current risks when providing guidance on PrEP duration
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for their clients, opting for a perceived simpler and
clearer message of the need for PrEP “for life”:
I think PrEP is for everyone, for life, because we are
exposed every day. If we were to say you have been
taking PrEP for 2 years you think you’re safe now.
Then for 5 months you don’t take it, then you expose
yourself [to risk] (Health care worker).
Social relations and their interactions with women’s
agency to use PrEP
Although many women explained that decisions to take
PrEP could afford them with a sense of autonomy over
their lives, a reported lack of shared decision-making, or
a perceived inability to disclose the decision to a partner
or family members could lead to challenges in continu-
ing PrEP. Women reported hiding their drugs under
mattresses or other places where nobody would find
them. This lack of visibility made some women forget to
take their pills, or made it difficult to do so in private:
It would be easier to take the pills if they knew about
it at home. I need to do everything in secrecy. If they
knew, there would maybe be someone to remind me
of the pills […] I have hidden my pills and I need to
look over my shoulder before taking it. If they knew, I
would keep the pills wherever I wanted, so when I
get to my bedroom, I see my pills and that would re-
mind me to take them (Woman 18–20 years).
Women who had not disclosed PrEP use to sexual
partners stated that taking PrEP was challenging when
they spent the night at their partner’s place, as they
feared being caught with the tablets. They feared nega-
tive responses from partners, such as being perceived as
promiscuous or HIV-positive. Around half of the partici-
pants reported that they had disclosed PrEP use to a sex-
ual partner and some stated how this led to arguments:
We quarrelled because of PrEP. It is as if he hears
from his friends that PrEP is for prostitutes. What is
the need for me to take PrEP? (Woman 18–20 years).
During focus group discussions, some male partici-
pants suggested that PrEP use by their partners might
provoke feelings of insecurity and lack of trust within a
relationship and that they may interpret its use as an ac-
cusation that they were infected with HIV, which could
in turn incline them towards physical violence against
their partners:
She must be thinking I have AIDS, that could annoy
me and I could end up beating her. (Male partici-
pant 1, FGD)...
He is right because I might be led to think that when
she is protecting herself, it is not because she has
many sexual partners. […] It could bring insecurity.
(Male participant 2, FGD).
On the other hand, all women in HIV-serodiscordant
relationships stated that their partners supported them
being on PrEP, which was also reported during FGDs
with men where it was seen to be appropriate:
“If I know I’m HIV-positive then I’ll understand
that this person is actually doing it for her safety
and my safety. By taking PrEP, she’s actually
thinking for both of us. We will both benefit”
(FGD with men).
Disclosing PrEP use to co-habiting family members
could lead to encouragement and pill reminders,
which promoted adherence, especially among those
who had children or were pregnant. In many cases,
women were celebrated for taking responsibility and
care for themselves and their child (ren). For some
women, however, disclosing PrEP use to co-habiting
family members meant being on the receiving end of
negative comments and attitudes that could under-
mine their motivation to continue PrEP. Young
women without children found it particularly difficult
to disclose PrEP use to parents or other parental au-
thorities at home, as they feared being sexually active
as a young, unmarried women would be judged mor-
ally unacceptable:
My father and my mother, I did not tell them […] I
don’t know if they know I’m sexually active. My par-
ents can really give me problems. They can say: ‘as
young as you are, you are taking these pills, and how
do you live your life?!’ (Woman 21–25 years).
Parental resistance towards PrEP was also mentioned
by healthcare workers, who were sometimes confronted
with angry parents during morning talks on PrEP in the
clinic. According to health workers, parents were report-
edly opposed PrEP as they perceived that it could en-
courage teenage children to be sexually active, rather
than protecting them from HIV infection risk through
abstinence:
During health talks, there is the challenge that some
parents aren’t able to accept. They say that if they
find these pills in the bedroom of the child, they
might chase the child away from home. ‘It is in our
nature as parents, we cannot accept that our child is
having sex’ and yet the child is just protecting herself
(Health care worker).
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Healthcare workers also mentioned how reaching
young people with PrEP was difficult, as they would
rarely come to the healthcare clinic, except young preg-
nant women who came for antenatal care.
Discussion
This study showed how an array of structural and social
factors influenced women’s agency to effectively harness
the prevention potential offered by PrEP. While PrEP
enabled women to achieve a sense of autonomy over
their own or their baby’s risk of acquiring HIV and en-
couraged a sense of self-worth and possibilities for self-
care, its longer-term use was often undermined by pill
fatigue, family expectations of young women, gender
norms, relationship dynamics and stigma related to HIV,
over which the women had less influence.
While PrEP was perceived to afford some autonomy
over HIV risks, as found elsewhere [18], our results also
highlight challenges in assuming responsibility for daily
pill taking “alone”, without support from family mem-
bers or partners, as was often the case for young women.
In alignment with other studies from the region, we
found that when disclosure was pursued, it did not al-
ways lead to acceptance or support from the women’s
family members or partners, which could trigger PrEP
discontinuation [23, 24].
Future access to two-three-monthly injectable PrEP
might reduce the need for women to disclose PrEP sta-
tus, as well as reducing the need for pill-taking re-
minders by family and partners. A recent study among
youth in South Africa demonstrated preference for long-
lasting PrEP in injectable or implant forms, highlighting
the benefits of the “invisibility” of such products [25, 26],
although other studies have demonstrated cases of in-
timate partner violence following the discovery of
monthly rings [27]. Furthermore, longer-lasting inter-
ventions do not address the social and structural chal-
lenges that contribute to HIV-related stigma that PrEP
users face, nor do they bring about the moral and emo-
tional support for being on PrEP that seem important
especially for AGYW. To address this, community-level
interventions could be carried out promoting PrEP ac-
ceptance among women’s partners and families and ad-
dressing the social norms that undermine its optimal
use. Adherence and support clubs could be beneficial for
AGYW on PrEP, regardless of its format, and their ef-
fectiveness for PrEP should be investigated [28]. As
young women without children often do not attend the
health clinic, other out-of-facility models are needed to
ensure they access PrEP in combination with family
planning measures.
Perceptions of the need for lifelong PrEP were driven
by the nature of many women’s relationships which were
often characterised as unstable or polygamous. As found
elsewhere, among sero-discordant couples, some women
were either unaware of the VL status of their partner or
did not trust the regularity of their pill-taking [29, 30].
These findings emphasise the importance of regular
counselling for PrEP recipients, with greater focus on
HIV transmission risks from partners on ART and sup-
port to discontinue and reinitiate PrEP as risks evolve.
Couple-counselling that focuses on mutual support for
ART and PrEP adherence could help reduce the time
which women need to remain on PrEP. Health workers
also need support to tailor risk assessments to each
woman, rather than assuming that their risk is lifelong.
The study had several limitations. It was conducted in
the context of a well-resourced demonstration project,
and perceptions of PrEP might change with time as the
intervention becomes more widely available or in set-
tings where fewer resources are available. Interviews
with health workers and women who discontinued or
declined PrEP were conducted once and could not cap-
ture how their experiences may have evolved. Finally, in-
sights from male partners and family members of
AGYW are lacking due to the ethical risks and chal-
lenges of recruiting these groups for IDIs in this setting.
Conclusions
In conclusion, we found that women’s motivations for
PrEP were driven by their perceptions of HIV risks and
their desire for self-care and control over their HIV
risks. However, these aspirations were often undermined
by social factors including gender norms within relation-
ships that drove stigmatising associations with pill-
taking, or within families where moralising attitudes lim-
ited support for PrEP for young women. Further re-
search should identify interventions to effectively
address these social and structural barriers to daily PrEP
taking and investigate how best to implement injectable
PrEP and out-of-facility PrEP, with integration into fam-
ily planning interventions for AGYW.
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